This company has been marked as potentially delisted and may not be actively trading. TenX Keane Acquisition (TENK) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsOwnershipTrendsBuy This Stock TENK vs. PULM, CYTH, CDIO, OVID, ENLV, NNVC, ELEV, CALC, LSTA, and LEXXShould you be buying TenX Keane Acquisition stock or one of its competitors? The main competitors of TenX Keane Acquisition include Pulmatrix (PULM), Cyclo Therapeutics (CYTH), Cardio Diagnostics (CDIO), Ovid Therapeutics (OVID), Enlivex Therapeutics (ENLV), NanoViricides (NNVC), Elevation Oncology (ELEV), CalciMedica (CALC), Lisata Therapeutics (LSTA), and Lexaria Bioscience (LEXX). These companies are all part of the "pharmaceutical products" industry. TenX Keane Acquisition vs. Pulmatrix Cyclo Therapeutics Cardio Diagnostics Ovid Therapeutics Enlivex Therapeutics NanoViricides Elevation Oncology CalciMedica Lisata Therapeutics Lexaria Bioscience TenX Keane Acquisition (NASDAQ:TENK) and Pulmatrix (NASDAQ:PULM) are both small-cap companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, media sentiment, community ranking, risk, earnings, institutional ownership, analyst recommendations, valuation and profitability. Do institutionals & insiders have more ownership in TENK or PULM? 70.5% of TenX Keane Acquisition shares are held by institutional investors. Comparatively, 11.8% of Pulmatrix shares are held by institutional investors. 22.9% of TenX Keane Acquisition shares are held by insiders. Comparatively, 0.6% of Pulmatrix shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the media favor TENK or PULM? In the previous week, TenX Keane Acquisition's average media sentiment score of 0.00 equaled Pulmatrix'saverage media sentiment score. Company Overall Sentiment TenX Keane Acquisition Neutral Pulmatrix Neutral Does the MarketBeat Community believe in TENK or PULM? Pulmatrix received 196 more outperform votes than TenX Keane Acquisition when rated by MarketBeat users. CompanyUnderperformOutperformTenX Keane AcquisitionN/AN/APulmatrixOutperform Votes19648.28% Underperform Votes21051.72% Which has stronger valuation & earnings, TENK or PULM? TenX Keane Acquisition has higher earnings, but lower revenue than Pulmatrix. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTenX Keane AcquisitionN/AN/AN/AN/AN/APulmatrix$7.81M3.00-$14.12M-$2.61-2.46 Is TENK or PULM more profitable? TenX Keane Acquisition has a net margin of 0.00% compared to Pulmatrix's net margin of -96.51%. TenX Keane Acquisition's return on equity of 0.00% beat Pulmatrix's return on equity.Company Net Margins Return on Equity Return on Assets TenX Keane AcquisitionN/A N/A N/A Pulmatrix -96.51%-45.97%-30.72% SummaryTenX Keane Acquisition beats Pulmatrix on 5 of the 7 factors compared between the two stocks. Get TenX Keane Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for TENK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TENK vs. The Competition Export to ExcelMetricTenX Keane AcquisitionHolding Offices Industry SectorNASDAQ ExchangeMarket Cap$6.15M$477.20M$2.45B$7.98BDividend YieldN/A7.88%13.13%4.21%P/E RatioN/A2.4310.9418.87Price / SalesN/A53.633,466,149.69106.74Price / CashN/A69.0159.3934.62Price / BookN/A3.653.444.32Net IncomeN/A$35.22M-$333.59M$247.98M TenX Keane Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TENKTenX Keane AcquisitionN/A$0.93+3.9%N/A-91.7%$6.15MN/A0.00N/AGap UpPULMPulmatrixN/A$6.51+3.3%N/A+225.5%$23.76M$7.81M-2.4720Upcoming EarningsCYTHCyclo TherapeuticsN/A$0.72flat$0.95+31.8%N/A$23.72M$870,725.00-0.809CDIOCardio Diagnostics1.623 of 5 stars$0.44-3.0%$2.00+352.5%-44.3%$23.05M$34,890.000.001OVIDOvid Therapeutics4.1213 of 5 stars$0.31-7.4%$3.03+868.2%-89.4%$22.27M$566,000.00-0.6760ENLVEnlivex Therapeutics2.6453 of 5 stars$1.03-1.5%$10.00+870.9%-35.8%$22.05MN/A-1.0570Gap UpNNVCNanoViricidesN/A$1.38+3.0%N/A+15.0%$21.59MN/A-1.9220News CoverageGap UpELEVElevation Oncology1.9389 of 5 stars$0.36+4.3%$3.39+837.4%-90.5%$21.39MN/A-0.4440CALCCalciMedica1.9461 of 5 stars$1.55+2.2%$18.00+1,058.3%-69.5%$20.95MN/A-1.4430Upcoming EarningsLSTALisata Therapeutics2.6611 of 5 stars$2.43-0.8%$15.00+517.3%-15.4%$20.95M$1M-0.9730Upcoming EarningsShort Interest ↓Positive NewsLEXXLexaria Bioscience2.3145 of 5 stars$1.19+1.6%$7.00+488.9%-62.0%$20.87M$525,923.00-2.387 Related Companies and Tools Related Companies PULM Alternatives CYTH Alternatives CDIO Alternatives OVID Alternatives ENLV Alternatives NNVC Alternatives ELEV Alternatives CALC Alternatives LSTA Alternatives LEXX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TENK) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TenX Keane Acquisition Please log in to your account or sign up in order to add this asset to your watchlist. Share TenX Keane Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TENK Stock Free TENK Stock Alerts